rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Aurobindo Pharma Ltd.

524804 AUROPHARMA Group (A)

05 Jul,15:29
1296.00
42.25 (3.37%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Aurobindo Pharma Ltd.

BUYSELL

47,607 1,253.75 1,311.00 - 1,254.90 1,292.15 - 695.75 75,932.64
NSE | BSE

Aurobindo Pharma Ltd.

AUROPHARMA

05 Jul,15:58
1303.55
48.90 (3.90%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Aurobindo Pharma Ltd.

BUYSELL

2,708,657 1254.65 1,311.80 - 1,255.00 1,292.10 - 714.75 3,505,868,928.24

News for Aurobindo Pharma Ltd.

Lupin, Eugia...
Lupin, Eugia Recall Products from US Market: USFDA
Lupin and Eugia, a unit of Aurobindo Pharma, are recalling products from the US market due to manufacturing issues. The USFDA has initiated Class II and Class III recalls for various medications....
Jun 23, 2024 11:22
Aurobindo Pharma...
Aurobindo Pharma Unit Inks Pact with MSD for Biologics Manufacturing
Aurobindo Pharma's TheraNym Biologics has signed a contract with MSD to set up a plant for contract manufacturing operations for biologicals, investing Rs 1,000 crore.
May 31, 2024 20:45
Aurobindo Pharma Q4 Net Profit Up 79.6% to Rs 909 Cr
Aurobindo Pharma's net profit surged 79.6% to Rs 909 crore in the March quarter, driven by strong revenue growth. Read more about the company's financial performance.
May 25, 2024 21:01
Dr Reddy's, Sun...
Dr Reddy's, Sun Pharma, Aurobindo Recall Products in US
Dr Reddy's, Sun Pharma, and Aurobindo Pharma are recalling products in the US market due to manufacturing issues, according to the latest USFDA Enforcement Report. The recalls include medications...
May 19, 2024 11:13
Aurobindo Pharma...
Aurobindo Pharma Faces Rs 13 cr Tax Demand for Ineligible ITC
Aurobindo Pharma received a tax demand of over Rs 13 crore from the GST authority for ineligible input tax credit claim. The company plans to appeal the order.
May 03, 2024 16:46

More News for Aurobindo Pharma Ltd. »

(Rs. Crore)

Financial Results of Aurobindo Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,645.6412,792.2811,287.1415,823.6813,266.48
Operating profit2,224.041,730.921,473.404,119.822,685.75
Interest182.60114.9816.9428.6895.58
Gross profit2,657.502,049.702,127.454,681.002,848.18
EPS (Rs)33.3521.0024.8353.1331.96

See more in Research Center »

News for Pharmaceuticals and health care

FSSAI Makes Bold...
FSSAI Makes Bold Food Labelling Mandatory: Salt, Sugar, Fat
The Food Safety and Standards Authority of India (FSSAI) has made bold labelling of salt, sugar, and saturated fat mandatory on packaged food items, aiming to help consumers make healthier choices....
Jul 06, 2024 19:38
Paytm Founder:...
Paytm Founder: Govt Mainstreamed Startups, Golden Era for Indian Entrepreneurs
Paytm founder Vijay Shekhar Sharma hails government's role in mainstreaming startups, calling it a golden period for Indian entrepreneurs. He highlights the shift from startups being at the bottom...
Jul 06, 2024 19:19
Future Consumer...
Future Consumer Defaults on Rs 449 Crore Payments
Future Consumer, FMCG arm of debt-ridden Future Group, has defaulted on payments of Rs 449.04 crore to banks and bondholders until June-end. The company is working on asset monetization and debt...
Jul 06, 2024 19:06
India's...
India's Semiconductor Ambitions: Global Player Potential
India aims to become a global semiconductor player, leveraging its expertise and government support. The industry is projected to reach a trillion dollars globally.
Jul 06, 2024 18:25
Bandhan Bank...
Bandhan Bank Appoints Interim MD & CEO - Ratan Kumar Kesh
Bandhan Bank has appointed Ratan Kumar Kesh as interim MD & CEO, effective July 10. Kesh, previously COO, will serve for three months or until a new CEO is appointed.
Jul 06, 2024 17:34

More News »

Top News

Vedanta Chairman...
Vedanta Chairman Meets Odisha CM, Discusses Development Projects
Vedanta Group chairman Anil Agarwal met Odisha Chief Minister Mohan Charan Majhi to discuss development projects and reiterate the company's commitment to the state's progress.
Jul 06, 2024 19:46
FSSAI Makes Bold...
FSSAI Makes Bold Food Labelling Mandatory: Salt, Sugar, Fat
The Food Safety and Standards Authority of India (FSSAI) has made bold labelling of salt, sugar, and saturated fat mandatory on packaged food items, aiming to help consumers make healthier choices....
Jul 06, 2024 19:38
Amit Shah: Coop...
Amit Shah: Coop Bank, Milk Union in Every District
Union Minister Amit Shah announces plans for cooperative banks and milk unions in each district, aiming to establish PACS in 2 lakh panchayats in the next 5 years.
Jul 06, 2024 19:24
Paytm Founder:...
Paytm Founder: Govt Mainstreamed Startups, Golden Era for Indian Entrepreneurs
Paytm founder Vijay Shekhar Sharma hails government's role in mainstreaming startups, calling it a golden period for Indian entrepreneurs. He highlights the shift from startups being at the bottom...
Jul 06, 2024 19:19
Future Consumer...
Future Consumer Defaults on Rs 449 Crore Payments
Future Consumer, FMCG arm of debt-ridden Future Group, has defaulted on payments of Rs 449.04 crore to banks and bondholders until June-end. The company is working on asset monetization and debt...
Jul 06, 2024 19:06

More Top News »

Report Card

PE Ratios
38.86
EPS (Rs.)
33.35
Sales (Rs. Cr)
2,894.03
Face Value (Rs.)
1
Net Profit Margin (%)
9.61
Last Bonus
1:1
Last Dividend(%)
150
Return on Average Equity
6.86

Compare 'Aurobindo Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,557.95
  • Compare
  • Divi's Laboratories Ltd.
  • 4,542.55
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,137.20
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,482.50
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,871.05
  • Compare
  • Max Healthcare Institute Ltd.
  • 917.55
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,232.50
  • Compare
  • Alkem Laboratories Ltd.
  • 4,977.35
  • Compare

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close